Dr. Renata Chalfin, MD

Dr. Chalfin practices at Neuroscience Consultants in Boca Raton, Florida.

Dr. Chalfin's NPI, 1043637143, was assigned on March 26, 2014. Dr. Chalfin graduated from University of Central Florida College of Medicine in 2014. Dr. Chalfin holds Florida license ME135504.

Dr. Chalfin's primary practice is Neuroscience Consultants, at 9970 Central Park N Blvd, Boca Raton, FL 33428 in Palm Beach County. The practice phone is (786) 924-1311.

Dr. Chalfin's primary practice is Neuroscience Consultants in Boca Raton, Florida. Dr. Chalfin is also affiliated with Boca Raton Regional Hospital. The medical group on file is First Choice Neurology. Dmand AI also links Dr. Chalfin to 1 more hospital, 5 medical groups, 2 group practices and clinics and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chalfin practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Chalfin's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Chalfin is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Chalfin's licenses on file in 15 states: Florida, Georgia, Montana, Oregon, Arizona, Iowa, Idaho, Kentucky, Louisiana, Maryland, Minnesota, Missouri, North Carolina, North Dakota and Nebraska.

Dmand AI lists alzheimer's disease, fibromyalgia and chronic pain, migraine and chronic headache, multiple sclerosis, neck pain and spine problems, nerve damage, neuropathy and parkinson's disease among the conditions Dr. Chalfin treats.

CMS data shows 995 Medicare services from Dr. Chalfin across 8 procedure codes in 2024, for 142 Medicare patients. Medicare paid $71,800 for them. Every service was in an office.

CMS counts 142 Medicare patients who saw Dr. Chalfin in 2024. The largest group is 75 to 84, with 55 patients. 75% of them have high cholesterol, and 71% have high blood pressure. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chalfin's median patient age at 72, with 63% women.

In 2024, Dr. Chalfin wrote 407 Medicare Part D claims for 80 patients. 94% of them were for generic drugs. CMS names the drug for 219 of them, across 10 drugs with 11 or more claims each, at $6,268 in total drug cost. In 2023, CMS named 47 claims across 3 drugs.

Dr. Chalfin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chalfin as offering telehealth.

Dmand AI links 1 paper to Dr. Chalfin in 2023. Dr. Chalfin's most frequent co-authors are Murtaza Amir, MD, Amanda Jane Avila, MD and Thomas G. Devlin, MD, PhD.

CMS Open Payments shows 100 general payments to Dr. Chalfin from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $258.

Dmand AI lists 5 awards for Dr. Chalfin, most recently Alpha Omega Alpha in 2014.

Dr. Chalfin graduated from University of Central Florida College of Medicine in 2014. Dr. Chalfin is a member of AAN and FMA.

Dr. Chalfin is in network with 11 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Cigna. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.